Narcotic analgesic combinations

RP n8 Pill - orange round

Pill with imprint RP n8 is Orange, Round and has been identified as Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual) 8 mg (base) / 2 mg (base). It is supplied by Rhodes Parmaceuticals L.P.

Buprenorphine/naloxone is used in the treatment of Opioid Use Disorder and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Buprenorphine/naloxone 8 mg (base) / 2 mg (base) is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).

Images

Buprenorphine and naloxone (oral/sublingual) (Buprenorphine and naloxone (oral/sublingual) [ bue-pre-nor-feen-and-nal-ox-one ])-RP n8-8 mg (base) / 2 mg (base)-Orange-Round

Buprenorphine and naloxone (oral/sublingual)
Generic Name: buprenorphine and naloxone (oral/sublingual) [ bue-pre-nor-feen-and-nal-ox-one ]
Imprint: RP n8
Strength: 8 mg (base) / 2 mg (base)
Color: Orange
Size: N/A
Shape: Round
Availability: Prescription only
Drug Class: Narcotic analgesic combinations
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: 3 - Moderate abuse potential
Labeler / Supplier: N/A
National Drug Code (NDC): 42858-0602
Inactive Ingredients:
Latest News
Related Drugs